LIN Feng, LI Yong. Perioperative Chemotherapy with FOLFOX4 and Surgery Versus Surgery Alone for Resectable Liver Metastases from Colorectal Cancer (EORTIC Intergroup Trial 40983): A Randomised Controlled Trial[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2009.03.016
|
Citation:
|
LIN Feng, LI Yong. Perioperative Chemotherapy with FOLFOX4 and Surgery Versus Surgery Alone for Resectable Liver Metastases from Colorectal Cancer (EORTIC Intergroup Trial 40983): A Randomised Controlled Trial[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2009.03.016
|
LIN Feng, LI Yong. Perioperative Chemotherapy with FOLFOX4 and Surgery Versus Surgery Alone for Resectable Liver Metastases from Colorectal Cancer (EORTIC Intergroup Trial 40983): A Randomised Controlled Trial[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2009.03.016
|
Citation:
|
LIN Feng, LI Yong. Perioperative Chemotherapy with FOLFOX4 and Surgery Versus Surgery Alone for Resectable Liver Metastases from Colorectal Cancer (EORTIC Intergroup Trial 40983): A Randomised Controlled Trial[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 147-149. DOI: 10.3969/j.issn.1671-5144.2009.03.016
|
DownLoad: